Abstract
Ralstonia mannitolilytica, a Gram-negative aerobic bacterium, is an opportunistic human pathogen that is becoming more common in cases of nosocomial infections. We report for the first time the whole-genome sequence analysis of R. mannitolilytica strain MRY14-0246, which carries the intrinsic OXA-443/OXA-22-like and OXA-444/OXA-60-like β-lactamase genes and is resistant to meropenem.
GENOME ANNOUNCEMENT
Ralstonia mannitolilytica, a Gram-negative aerobic bacterium belonging to the genus Ralstonia, is prevalent in water supplies and is becoming more common in cases of nosocomial infections (1). R. mannitolilytica is closely related to Ralstonia pickettii and had previously been named “Pseudomonas thomasii” and R. pickettii biovar 3/“thomasii” (1, 2). In 2001, R. mannitolilytica was classified as a novel species in the genus Ralstonia, based on 16S rRNA gene sequence analysis (2). R. mannitolilytica is known as an opportunistic human pathogen, possibly associated with cystic fibrosis (3), and the clinical isolates frequently exhibit resistance to imipenem (4). However, little is known about drug resistance and virulence phenotypes of R. mannitolilytica because its genetic basis is uncertain.
In this report, we announce the first draft genome sequence of R. mannitolilytica. R. mannitolilytica strain MRY14-0246 was recovered from a patient’s urine in a medical institution in Japan and was resistant to meropenem, according to the MIC determined using the Vitek2 system and an Etest (bioMérieux) and applying the recommended breakpoints described by the CLSI (5). Whole-genome shotgun sequencing of strain MRY14-0246 was performed using the Illumina HiSeq 2500 pyrosequencing platform (500- to 750-bp insert size). Paired-end reads (2 × 150 bp) were assembled de novo using CLC Genomics Workbench version 7.5.1 (Qiagen). The draft genome sequence of strain MRY14-0246 consisted of 48 contigs, yielding total sequences of 4,671,011 bp with N50 contig sizes of 328,267 bp. The mean G+C content was 65.8%. A total of 4,357 coding DNA sequences were annotated by the RAST server version 2.0 (http://rast.nmpdr.org). The 16S rRNA gene sequence of strain MRY14-0246 almost matched that of the R. mannitolilytica type strain LMG 6866T (GenBank accession number AJ270258) (99.8%). Strain MRY14-0246 carried two novel class D β-lactamase gene variants, which we named blaOXA-443 and blaOXA-444 (accession numbers LC030178 and LC030179, respectively).
The blaOXA-443 and blaOXA-444 genes in strain MRY14-0246 are encoded in contigs 8_1 and 10_1 (accession numbers BBUP01000016 and BBUP01000018), respectively, both of which are parts of the chromosome with no transposable element, suggesting that these oxacillinase genes are intrinsically species-specific in R. mannitolilytica. R. pickettii produces two resident oxacillinases named OXA-22 and OXA-60 (6, 7). Unlike OXA-22, which is a narrow-spectrum oxacillinase, OXA-60 is an extended-spectrum oxacillinase with carbapenem-hydrolyzing properties (6). The OXA-443 and OXA-444 proteins exhibit close similarities to OXA-22 and OXA-60 (86.0% and 90.3% amino acid identities), respectively, suggesting that OXA-444/OXA-60-like β-lactamase could contribute to carbapenem resistance in strain MRY14-0246.
Bacterial pathogens frequently use protein secretion systems to interact with their hosts. The type III secretion system (T3SS) and type VI secretion system (T6SS) are known as major virulence factors of the plant pathogen Ralstonia solanacearum (8, 9). Strain MRY14-0246 does not contain the T3SS gene cluster, whereas the strain contains the T6SS gene cluster and two hcp and four vgrG translocator genes. T6SS delivers effectors into neighboring organisms, including bacteria and hosts, leading to cytotoxicity and cell death of targets (10). Hence, T6SS could be an important virulence determinant in R. mannitolilytica. A more detailed report of strain MRY14-0246 will be included in a future publication.
Nucleotide sequence accession numbers.
The whole-genome shotgun projects of R. mannitolilytica strain MRY14-0246 have been deposited at DDBJ/EMBL/GenBank under the accession number BBUP00000000. The version described in this paper is the first version, BBUP00000000.1.
ACKNOWLEDGMENTS
We thank Kumiko Kai, Yoshie Taki, and Hiromi Toyoizumi for technical assistance and Karen Bush for helping with the nomenclature of the OXA-443 and OXA-444 β-lactamase genes. We are grateful to the participating medical institution for providing the strain and clinical information.
This work is supported by a Grant-in-Aid for Young Scientists (A) (25713017) from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and by Grants-in-Aid for Shiga Infection Control Network and H24-Shinkou-Ippan-010 from the Ministry of Health, Labour and Welfare, Japan.
Footnotes
Citation Suzuki M, Nishio H, Asagoe K, Kida K, Suzuki S, Matsui M, Shibayama K. 2015. Genome sequence of a carbapenem-resistant strain of Ralstonia mannitolilytica. Genome Announc 3(3):e00405-15. doi:10.1128/genomeA.00405-15.
REFERENCES
- 1.Ryan MP, Adley CC. 2014. Ralstonia spp.: emerging global opportunistic pathogens. Eur J Clin Microbiol Infect Dis 33:291–304. doi: 10.1007/s10096-013-1975-9. [DOI] [PubMed] [Google Scholar]
- 2.De Baere T, Steyaert S, Wauters G, Des Vos P, Goris J, Coenye T, Suyama T, Verschraegen G, Vaneechoutte M. 2001. Classification of Ralstonia pickettii biovar 3/“thomasii” strains (Pickett 1994) and of new isolates related to nosocomial recurrent meningitis as Ralstonia mannitolytica sp. nov. Int J Syst Evol Microbiol 51:547–558. [DOI] [PubMed] [Google Scholar]
- 3.Coenye T, Spilker T, Reik R, Vandamme P, Lipuma JJ. 2005. Use of PCR analyses to define the distribution of Ralstonia species recovered from patients with cystic fibrosis. J Clin Microbiol 43:3463–3466. doi: 10.1128/JCM.43.7.3463-3466.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Daxboeck F, Stadler M, Assadian O, Marko E, Hirschl AM, Koller W. 2005. Characterization of clinically isolated Ralstonia mannitolilytica strains using random amplification of polymorphic DNA (RAPD) typing and antimicrobial sensitivity, and comparison of the classification efficacy of phenotypic and genotypic assays. J Med Microbiol 54:55–61. doi: 10.1099/jmm.0.45656-0. [DOI] [PubMed] [Google Scholar]
- 5.Clinical and Laboratory Standards Institute 2015. Performance standards for antimicrobial susceptibility testing: 25th informational supplement (m100-S25). Clinical and Laboratory Standards Institute, Wayne, PA. [Google Scholar]
- 6.Girlich D, Naas T, Nordmann P. 2004. OXA-60, a chromosomal, inducible, and imipenem-hydrolyzing class D β-lactamase from Ralstonia pickettii. Antimicrob Agents Chemother 48:4217–4225. doi: 10.1128/AAC.48.11.4217-4225.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Nordmann P, Poirel L, Kubina M, Casetta A, Naas T. 2000. Biochemical-genetic characterization and distribution of OXA-22, a chromosomal and inducible class D β-lactamase from Ralstonia (Pseudomonas) pickettii. Antimicrob Agents Chemother 44:2201–2204. doi: 10.1128/AAC.44.8.2201-2204.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Deslandes L, Genin S. 2014. Opening the Ralstonia solanacearum type III effector tool box: insights into host cell subversion mechanisms. Curr Opin Plant Biol 20:110–117. doi: 10.1016/j.pbi.2014.05.002. [DOI] [PubMed] [Google Scholar]
- 9.Zhang L, Xu J, Xu J, Zhang H, He L, Feng J. 2014. TssB is essential for virulence and required for type VI secretion system in Ralstonia solanacearum. Microb Pathog 74:1–7. doi: 10.1016/j.micpath.2014.06.006. [DOI] [PubMed] [Google Scholar]
- 10.Russell AB, Peterson SB, Mougous JD. 2014. Type VI secretion system effectors: poisons with a purpose. Nat Rev Microbiol 12:137–148. doi: 10.1038/nrmicro3185. [DOI] [PMC free article] [PubMed] [Google Scholar]